NO20001871L - Nye 3,6-hemiacetaler fra klassen 9a-azalider - Google Patents

Nye 3,6-hemiacetaler fra klassen 9a-azalider

Info

Publication number
NO20001871L
NO20001871L NO20001871A NO20001871A NO20001871L NO 20001871 L NO20001871 L NO 20001871L NO 20001871 A NO20001871 A NO 20001871A NO 20001871 A NO20001871 A NO 20001871A NO 20001871 L NO20001871 L NO 20001871L
Authority
NO
Norway
Prior art keywords
group
individually
represents hydrogen
carbon atoms
individually represents
Prior art date
Application number
NO20001871A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001871D0 (no
Inventor
Gabrijela Kobrehel
Gorjana Lazarevski
Mladen Vinkovic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HR970551A external-priority patent/HRP970551B1/xx
Priority claimed from HR980497A external-priority patent/HRP980497B1/xx
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of NO20001871D0 publication Critical patent/NO20001871D0/no
Publication of NO20001871L publication Critical patent/NO20001871L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20001871A 1997-10-16 2000-04-11 Nye 3,6-hemiacetaler fra klassen 9a-azalider NO20001871L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HR970551A HRP970551B1 (en) 1997-10-16 1997-10-16 Novel o-methyl azythromycin derivatives
HR980497A HRP980497B1 (en) 1998-09-10 1998-09-10 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
PCT/HR1998/000005 WO1999020639A2 (fr) 1997-10-16 1998-10-13 NOUVEAUX 3,6-HEMICETALS APPARTENANT A LA CLASSE DES 9a-AZALIDES

Publications (2)

Publication Number Publication Date
NO20001871D0 NO20001871D0 (no) 2000-04-11
NO20001871L true NO20001871L (no) 2000-04-17

Family

ID=26317108

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001871A NO20001871L (no) 1997-10-16 2000-04-11 Nye 3,6-hemiacetaler fra klassen 9a-azalider

Country Status (25)

Country Link
US (1) US6369035B1 (fr)
EP (2) EP1437359B1 (fr)
JP (1) JP2001520234A (fr)
KR (1) KR100554549B1 (fr)
CN (1) CN1281615C (fr)
AR (1) AR018014A1 (fr)
AT (2) ATE348836T1 (fr)
AU (1) AU755315B2 (fr)
BG (1) BG64650B1 (fr)
BR (1) BR9812808A (fr)
CA (1) CA2306963C (fr)
DE (2) DE69836697T2 (fr)
DK (2) DK1036083T5 (fr)
EE (1) EE04681B1 (fr)
ES (2) ES2222610T3 (fr)
HU (1) HUP0004085A3 (fr)
IL (2) IL135648A0 (fr)
NO (1) NO20001871L (fr)
NZ (1) NZ503897A (fr)
PL (1) PL191087B1 (fr)
PT (2) PT1437359E (fr)
RU (1) RU2220148C2 (fr)
SI (2) SI1036083T1 (fr)
SK (1) SK285914B6 (fr)
WO (1) WO1999020639A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20011512A3 (cs) * 1998-11-03 2001-09-12 Pfizer Products Inc. Nová makrolidová antibiotika
KR100361397B1 (ko) * 2000-03-15 2002-11-23 한미약품공업 주식회사 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법
NZ535354A (en) 2002-02-15 2008-01-31 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1482957A4 (fr) 2002-02-15 2006-07-19 Merckle Gmbh Conjugues antibiotiques
EP1483579A4 (fr) 2002-02-15 2006-07-12 Merckle Gmbh Conjugues de composes biologiquement actifs, methodes de preparation et d'utilisation des conjugues, formulation et applications pharmaceutiques obtenues a partir desdits conjugues
HRP20020779A2 (en) 2002-09-27 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US7435805B2 (en) * 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
AU2003264910A1 (en) * 2003-05-30 2005-01-21 Pliva - Istrazivacki Institut D.O.O. Process for selective alkylation of macrolide and azalide derivatives
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7271155B2 (en) * 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
WO2008106204A1 (fr) * 2007-02-28 2008-09-04 Rib-X-Pharmaceuticals, Inc. Composés macrolides et procédés de fabrication et d'utilisation de ceux-ci
US9145436B2 (en) 2010-10-10 2015-09-29 Michael W. Burnet Anti-inflammatory macrolides
WO2013148874A1 (fr) * 2012-03-27 2013-10-03 Burnet Michael W Macrolides anti-inflammatoires
JP7184520B2 (ja) * 2018-01-22 2022-12-06 旭化成株式会社 トランス型脂環式カーボネートの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
DE3860503D1 (de) * 1987-09-03 1990-10-04 Pliva Pharm & Chem Works 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
WO1989002271A1 (fr) * 1987-09-10 1989-03-23 Pfizer Azithromycine et derives utilises comme agents anti-protozoaires
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
JP2880338B2 (ja) * 1991-10-25 1999-04-05 株式会社森組 圧搾気体による被移送物の圧送方式
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
WO1999000124A1 (fr) * 1997-06-26 1999-01-07 Merck & Co., Inc. 9a-azalides, compositions a base de ces composes et procedes therapeutiques

Also Published As

Publication number Publication date
HK1032785A1 (en) 2001-08-03
PL191087B1 (pl) 2006-03-31
WO1999020639A3 (fr) 1999-07-08
SK5522000A3 (en) 2000-11-07
SI1437359T1 (sl) 2007-06-30
PL340372A1 (en) 2001-01-29
EP1036083A2 (fr) 2000-09-20
HUP0004085A2 (hu) 2001-04-28
DE69836697D1 (de) 2007-02-01
CA2306963C (fr) 2007-05-01
CN1281615C (zh) 2006-10-25
DE69824201T2 (de) 2005-09-22
SI1036083T1 (en) 2004-10-31
PT1437359E (pt) 2007-04-30
BR9812808A (pt) 2005-04-12
EE04681B1 (et) 2006-08-15
IL135648A (en) 2007-03-08
BG64650B1 (bg) 2005-10-31
KR20010031160A (ko) 2001-04-16
ATE267835T1 (de) 2004-06-15
EP1437359B1 (fr) 2006-12-20
CN1280585A (zh) 2001-01-17
DK1036083T5 (da) 2005-04-04
EE200000226A (et) 2001-06-15
KR100554549B1 (ko) 2006-03-03
EP1036083B9 (fr) 2005-01-12
JP2001520234A (ja) 2001-10-30
ATE348836T1 (de) 2007-01-15
IL135648A0 (en) 2001-05-20
AU755315B2 (en) 2002-12-12
ES2222610T3 (es) 2005-02-01
DK1036083T3 (da) 2004-09-27
HUP0004085A3 (en) 2003-05-28
NZ503897A (en) 2002-10-25
RU2220148C2 (ru) 2003-12-27
ES2279242T3 (es) 2007-08-16
BG104445A (en) 2001-02-28
AR018014A1 (es) 2001-10-31
WO1999020639A2 (fr) 1999-04-29
EP1437359A2 (fr) 2004-07-14
CA2306963A1 (fr) 1999-04-29
DE69836697T2 (de) 2007-10-04
PT1036083E (pt) 2004-10-29
DK1437359T3 (da) 2007-04-30
DE69824201D1 (de) 2004-07-01
AU9362298A (en) 1999-05-10
SK285914B6 (sk) 2007-11-02
EP1437359A3 (fr) 2005-03-30
US6369035B1 (en) 2002-04-09
EP1036083B1 (fr) 2004-05-26
NO20001871D0 (no) 2000-04-11

Similar Documents

Publication Publication Date Title
NO20001871L (no) Nye 3,6-hemiacetaler fra klassen 9a-azalider
YU47099B (sh) Postupak za dobijanje makrolidnih jedinjenja
PL358428A1 (en) 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
EA200200774A1 (ru) Новые соединения, обладающие гиполипидемической, гипохолестеринемической активностью, способ их получения и содержащие их композиции
ES431059A1 (es) Procedimiento para la preparacion de nuevos n-(metoximetil - furilmetil)-6, 7-benzomorfanos y -morfinanos.
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
KR930016436A (ko) 4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물
MX9600503A (es) 10-aminoalifatil-dibenz(b,f)oxepinas anti-neurodegenerativamente activas.
KR840003646A (ko) 20-아미노틸로신 유도체의 제조방법
KR860008111A (ko) 인딘과 나프탈렌 유도체의 제조방법
IE43847L (en) N-substituted phenylpiperidine derivatives.
DE60043293D1 (de) VAKUOLAR-TYP (H+)-ATPase-HEMMENDE VERBINDUNGEN, ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
NO20006350L (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
NO970766D0 (no) Fremgangsmåte for fremstilling av taxol og derivater derav
ES2142771A1 (es) Nuevos derivados de la 6-(4-penilbutoxi) hexilamina y procedimiento para la obtencion de salmeterol.
EA200101209A1 (ru) Новые производные бензола, способ их получения и фармацевтические композиции, содержащие их
KR870003107A (ko) 키산틴 유도체의 제조방법
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.
DE3788149D1 (de) Prostazyklin-(PGI2)-Analoge.
CO4810380A1 (es) Derivados de eritromicina
ATE354580T1 (de) Oleandomycin-derivate
IL66384A0 (en) Sulphimines and salts thereof,their preparation and pharmaceutical compositions containing them
EA200101050A1 (ru) Замещенные бензолактамные соединения

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application